Kassa_1998_Hum.Exp.Toxicol_17_331

Reference

Title : A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats - Kassa_1998_Hum.Exp.Toxicol_17_331
Author(s) : Kassa J
Ref : Hum Exp Toxicol , 17 :331 , 1998
Abstract :

1. The influence of three oximes (obidoxime, HI-6 and the new asymmetric bispyridinium oxime BI-6) in combination with atropine on soman-induced cholinergic and stressogenic effects in rats was studied. 2. The oxime BI-6 produced significantly higher reactivation of soman-inhibited blood and diaphragm cholinesterases than obidoxime. On the other hand, its reactivating effect was not so high as the effect of the oxime HI-6. 3. There were not significant differences in the reactivation of soman-inhibited brain acetylcholinesterase among all three oximes tested. 4. The influence of the oxime BI-6 on soman-induced stressogenic effects was greater than the antistressogenic effects of HI-6 or obidoxime at 1 h or 3 h following soman poisoning. 5 These findings confirm that the oxime BI-6 has no definite advantages over HI-6 in the antidotal treatment of soman poisoning but BI-6 is significantly more effective in rats than obidoxime, one of the oximes presently in use.

PubMedSearch : Kassa_1998_Hum.Exp.Toxicol_17_331
PubMedID: 9688357

Related information

Inhibitor Soman
Reactivator BI-6    Toxogonin    HI-6

Citations formats

Kassa J (1998)
A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats
Hum Exp Toxicol 17 :331

Kassa J (1998)
Hum Exp Toxicol 17 :331